The United States Patent and Trademark Office (USPTO) has issued patent US12578345B2 to The Board of Regents, The University of Texas System, for novel methods of single molecule peptide sequencing. The patent, filed on October 24, 2023, and granted on March 17, 2026, details techniques for identifying polypeptide sequences within a heterogeneous mixture. These methods involve immobilizing a polypeptide with labeled amino acid residues to a support, detecting signals or signal changes, and then subjecting the polypeptide to conditions that remove amino acid residues.

This patent grant represents a new intellectual property asset in the field of peptide analysis and sequencing. While it does not impose direct compliance obligations on regulated entities, it may impact research and development strategies for pharmaceutical companies, biotechnology firms, and academic institutions involved in peptide discovery, drug development, and diagnostics. Companies operating in these sectors should be aware of this granted patent, as it could affect their freedom to operate or potential licensing opportunities related to peptide sequencing technologies.